Results 81 to 90 of about 67,015 (304)

Takotsubo Cardiomyopathy Mimicking Obstructive Hypertrophic Cardiomyopathy

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Takotsubo cardiomyopathy (TCM) is characterized by transient left ventricular dysfunction, diagnosed via echocardiography or left ventriculography. In most cases, TCM involves an emotional, physical, or combined trigger. Acute coronary syndrome is one of the most frequent misdiagnoses in TCM patients due to electrocardiogram (ECG) abnormalities and ...
Samuray, Zekeriyeyev, Uğur, Canpolat
openaire   +2 more sources

Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy　- The HORIZON-HCM Study.

Circulation Journal
BACKGROUND Mavacamten, a cardiac myosin inhibitor, significantly improved symptoms and cardiac function vs. placebo in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in EXPLORER-HCM.
Hiroaki Kitaoka, Masaki Ieda, M. Ebato, Ken Kozuma, M. Takayama, Kaoru Tanno, Nobuyuki Komiyama, Yasushi Sakata, Y. Maekawa, Y. Minami, A. Ogimoto, Tomohide Takaya, Satoshi Yasuda, E. Amiya, Yutaka Furukawa, Tetsuya Watanabe, D. Hiraya, H. Miyagoshi, Gen Kinoshita, Alison Reedy, S. M. Hegde, Victoria Florea, Chisato Izumi   +22 more
semanticscholar   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography

Echo Research and Practice, 2021
Hypertrophic cardiomyopathy (HCM) is common, inherited and characterised by unexplained thickening of the myocardium. The British Society of Echocardiography (BSE) has recently published a minimum dataset for transthoracic echocardiography detailing the ...
Lauren Turvey, Daniel X Augustine, Shaun Robinson, David Oxborough, Martin Stout, Nicola Smith, Allan Harkness, Lynne Williams, Richard P Steeds, William Bradlow   +9 more
doaj   +1 more source

Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM

European Journal of Heart Failure
The aim of this study was to report safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy (nHCM) over 36 weeks in the ongoing FOREST‐HCM trial.
A. Masri, R. Barriales-Villa, Perry M Elliott, M. Nassif, A. Oręziak, A. Owens, A. Tower-Rader, S. Heitner, S. Kupfer, F. Malik, C. Melloni, L. Meng, Jenny Wei, S. Saberi   +13 more
semanticscholar   +1 more source

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long‐Term Follow‐Up of Deformations and Hemodynamics

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA). Purpose To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics ...
Kenichiro Suwa, Kazuto Ohno, Terumori Satoh, Ryota Sato, Keisuke Iguchi, Yuichiro Maekawa   +5 more
wiley   +1 more source

Midventricular Obstructive Hypertrophic Cardiomyopathy during Pregnancy Complicated by Pulmonary Embolism: A Case Report

Case Reports in Medicine, 2012
Hypertrophic cardiomyopathy (HCM) with midventricular obstruction (MVO) is a rare condition occurring in 1% of HCM patients. It is characterized by asymmetric left ventricular hypertrophy with MVO and elevated intraventricular pressure gradients ...
Leila Abid, Ahmed Tounsi, Dorra Abid, Mourad Hentati, Samir Kammoun   +4 more
doaj   +1 more source

Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy [PDF]

, 2008
Objectives: To investigate the relationship between the plasma B-type natriuretic peptide (BNP) level and the occurrence of atrial fibrillation (AF) in nonobstructive hypertrophic cardiomyopathy (HCM) patients.
Hina, Kazuyoshi, Kawamura, Hiroshi, Kusachi, Shozo, Matsuura, Hiroko, Murakami, Takashi, Ninomiya, Yoshifumi, Shinohata, Ryoko, Sogo, Taiji, Usui, Shinichi, Yamamoto, Keizo   +9 more
core   +1 more source

Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany

European Heart Journal, 2022
While numerous publications have estimated the prevalence of diagnosed hypertrophic cardiomyopathy (HCM), none have quantified the real-world proportion of obstructive and non-obstructive HCM using nationally representative data sources in any ...
M. Schultze, C. Zema, R. Carroll, M. Hurst, J. Borchert, Y. Zhong, T. Krause, T. Bluhmki, H. Partington, F. Osman, M. Tome Esteban   +10 more
semanticscholar   +1 more source

Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol

BMC Veterinary Research, 2019
Background Inconsistency of treatment response in cats with obstructive hypertrophic cardiomyopathy is well recognized. We hypothesized that the difference in response to beta-blockers may be caused by myocardial functional abnormalities.
Ryohei Suzuki, Yohei Mochizuki, Yunosuke Yuchi, Yuyo Yasumura, Takahiro Saito, Takahiro Teshima, Hirotaka Matsumoto, Hidekazu Koyama   +7 more
doaj   +1 more source